Low PNI (PNI < 37: n = 17) | High PNI (PNI ≥ 37: n = 172) | p value | |
---|---|---|---|
PNI median | 33.6 (26.0–36.9) | 45.9 (37.3–60.0) | |
Tumor size (cm) | 4.7 (1.1–15.0) | 4.0 (0.5–24.0) | n.s |
Multiple tumor | 7 (41%) | 42 (24%) | n.s |
AFP (ng/ml) | 62 (2–60,105) | 11 (1–253,875) | 0.05 |
DCP (mAU/ml) | 1094 (14–85,330) | 92 (1–286,400) | n.s |
BCLC stage | n.s | ||
0 | 0 (0%) | 17 (10%) | |
A | 13 (76%) | 108 (63%) | |
B | 3 (18%) | 35 (20%) | |
C | 1 (6%) | 12 (7%) | |
Within Milan criteria | 9 (53%) | 98 (57%) | n.s |
Tumor differentiation | |||
Well | 2 (13%) | 40 (28%) | n.s |
Moderately | 10 (62%) | 80 (56%) | |
Poorly | 4 (25%) | 22 (16%) | |
Vascular invasion | |||
vp ( +) | 9 (56%) | 55 (38%) | n.s |
vv ( +) | 1 (6%) | 11 (8%) | n.s |
Operation time (minutes) | 336 (159–526) | 335 (127–983) | n.s |
Blood loss (ml) | 1711 (520–10,382) | 1080 (0–36,000) | n.s |
≥ 2 sectionectomy | 3 (18%) | 54 (31%) | n.s |
Complications (C-D ≥ IIIa) | 5 (29%) | 33 (20%) | n.s |
Mortality | 2 (12%) | 8 (5%) | n.s |
PT-INR on POD5 | 1.20 (0.98–1.71) | 1.12 (0.92–1.52) | 0.03 |
Total bilirubin on POD5 (mg/dl) | 1.5 (0.5–11.2) | 0.9 (0.3–8.3) | 0.012 |